Published in
American Society of Hematology, Blood, 6(128), p. 805-815, 2016
DOI: 10.1182/blood-2016-01-694117
Links
- ORCID
- American Society of Hematology | PDF
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB
Journal article published in 2016 by
Jan P. Nicolay,
Karin Müller-Decker,
Anne Schroeder,
Markus Brechmann,
Markus Möbs 
,
Cyrill Géraud,
Chalid Assaf,
Sergij Goerdt,
Peter H. Krammer,
Karsten Gülow
,
Cyrill Géraud,
Chalid Assaf,
Sergij Goerdt,
Peter H. Krammer,
Karsten Gülow
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points DMF induces specific cell death in CTCL cells and inhibits CTCL tumor growth and metastasis in vivo via inhibition of NF-κB. DMF therefore represents a promising, nontoxic novel therapeutic approach to treating CTCL.